Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick F Lang

Showing results (121-130 of 251) with videos related to

Pageof 26
Sort By:
Journal of the National Cancer Institute|September 13, 2007
Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell deathHong Jiang, Candelaria Gomez-Manzano, Hiroshi Aoki, et al.
Experimental Cell Research|August 26, 2018
Distinct mechanisms enable inward or outward budding from late endosomes/multivesicular bodiesMonica Gireud-Goss, Sahily Reyes, Marenda Wilson, et al.
Journal of Neuro-Oncology|June 25, 2025
Molecular and clinical determinants of response to checkpoint inhibitor immunotherapy in glioblastomaPushan Dasgupta, Heather Lin, Gayatri Kumar, et al.
Journal of Neurosurgery|August 27, 2021
Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastomaYuzaburo Shimizu, Joy Gumin, Feng Gao, et al.
Neuro-Oncology Advances|November 26, 2020
RNAi technology targeting the <i>FGFR3-TACC3</i> fusion breakpoint: an opportunity for precision medicineBrittany C Parker Kerrigan, Daniel Ledbetter, Matthew Kronowitz, et al.
Neuro-Oncology|April 30, 2008
Phosphorylation of Thr18 and Ser20 of p53 in Ad-p53-induced apoptosisAkira Nakamizo, Toshiyuko Amano, Wei Zhang, et al.
Neuro-Oncology Advances|October 15, 2019
GITRL-armed Delta-24-RGD oncolytic adenovirus prolongs survival and induces anti-glioma immune memoryYisel Rivera-Molina, Hong Jiang, Juan Fueyo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecanCandelaria Gomez-Manzano, Marta M Alonso, W K Alfred Yung, et al.
Journal of Proteome Research|March 5, 2010
Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiationHuan He, Carol L Nilsson, Mark R Emmett, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 18, 2023
Glial Cell Adhesion Molecule (GlialCAM) Determines Proliferative versus Invasive Cell States in GlioblastomaArpan De, John M Lattier, John E Morales, et al.
Pageof 26

Showing results (121-130 of 251) with videos related to

Sort By:
Pageof 26
Journal of the National Cancer Institute|September 13, 2007
Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell deathHong Jiang, Candelaria Gomez-Manzano, Hiroshi Aoki, et al.
Experimental Cell Research|August 26, 2018
Distinct mechanisms enable inward or outward budding from late endosomes/multivesicular bodiesMonica Gireud-Goss, Sahily Reyes, Marenda Wilson, et al.
Journal of Neuro-Oncology|June 25, 2025
Molecular and clinical determinants of response to checkpoint inhibitor immunotherapy in glioblastomaPushan Dasgupta, Heather Lin, Gayatri Kumar, et al.
Journal of Neurosurgery|August 27, 2021
Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastomaYuzaburo Shimizu, Joy Gumin, Feng Gao, et al.
Neuro-Oncology Advances|November 26, 2020
RNAi technology targeting the <i>FGFR3-TACC3</i> fusion breakpoint: an opportunity for precision medicineBrittany C Parker Kerrigan, Daniel Ledbetter, Matthew Kronowitz, et al.
Neuro-Oncology|April 30, 2008
Phosphorylation of Thr18 and Ser20 of p53 in Ad-p53-induced apoptosisAkira Nakamizo, Toshiyuko Amano, Wei Zhang, et al.
Neuro-Oncology Advances|October 15, 2019
GITRL-armed Delta-24-RGD oncolytic adenovirus prolongs survival and induces anti-glioma immune memoryYisel Rivera-Molina, Hong Jiang, Juan Fueyo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecanCandelaria Gomez-Manzano, Marta M Alonso, W K Alfred Yung, et al.
Journal of Proteome Research|March 5, 2010
Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiationHuan He, Carol L Nilsson, Mark R Emmett, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 18, 2023
Glial Cell Adhesion Molecule (GlialCAM) Determines Proliferative versus Invasive Cell States in GlioblastomaArpan De, John M Lattier, John E Morales, et al.
Pageof 26